跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOPICAL HAPTEN GEL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TOPICAL HAPTEN GEL
Authorized
STANDARD
TOPICAL HAPTEN GEL
dormer laboratories inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d86fc198a7d7c626
Company
dormer laboratories inc.
Type
Standard
Approval Details
Approval Id
d86fc198a7d7c626
Drug Approval Canada Name
TOPICAL HAPTEN GEL
Product Name
TOPICAL HAPTEN GEL
Status
Marketed
Status Date
2017-09-13
Original Market Date
2017-09-13
Din
02466325
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
Schedule D
Ahfs
92:05.00*
Atc Original
V04CL TESTS FOR ALLERGIC DISEASES
Atc Name
v 04 cl
Aig Number
0159290001
Company Name
dormer laboratories inc.
Company Address
5, 91 Kelfield Street, Toronto, Ontario, Canada, M9W 5A3
Active Ingredients
HAPTENS
50 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d86fc198a7d7c626
Type
Standard
Back to Health Canada Approvals